Bristol Myers Squibb Non-GAAP EPS $1.99 beat $0.16, income of $11.22 billion beat $40 million, reaffirms FY22 outlook
Bristol Myers Squibb Non-GAAP EPS $1.99 beat $0.16, income of $11.22 billion beat $40 million, reaffirms FY22 outlook
Bristol Myers Squibb Non-GAAP EPS $1.99 beat $0.16, income of $11.22 billion beat $40 million, reaffirms FY22 outlook